4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001878824-26-000004
Chief Financial Officer gave up 11,904 shares (to pay taxes)
- Chief Financial Officer acquired 35,420 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCombe William D. Chief Financial Officer | 2026-08-18 | Option exercise | +6,320 | 117,497 | D | ||
| McCombe William D. Chief Financial Officer | 2026-08-18 | Shares withheld for taxes | −2,111 | $4.67 | $9,858 | 115,386 | D |
| McCombe William D. Chief Financial Officer | 2026-08-18 | Option exercise | +13,051 | 128,437 | D | ||
| McCombe William D. Chief Financial Officer | 2026-08-18 | Shares withheld for taxes | −4,392 | $4.67 | $20,511 | 124,045 | D |
| McCombe William D. Chief Financial Officer | 2026-08-18 | Option exercise | +16,049 | 140,094 | D | ||
| McCombe William D. Chief Financial Officer | 2026-08-18 | Shares withheld for taxes | −5,401 | $4.67 | $25,223 | 134,693 | D |
| Derivatives | |||||||
| McCombe William D. Chief Financial Officer | 2026-08-18 | Option exercise · Restricted Stock Units | −6,320 | 44,249 | D | ||
| McCombe William D. Chief Financial Officer | 2026-08-18 | Option exercise · Restricted Stock Units | −13,051 | 134,862 | D | ||
| McCombe William D. Chief Financial Officer | 2026-08-18 | Option exercise · Restricted Stock Units | −16,049 | 230,042 | D | ||
Loading xslF345X06/form4-08202026_080854.xml…